glycyrrhizic acid has been researched along with Brain Swelling in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, WR; Guo, C; Li, YM; Lu, HD; Sun, JG; Wang, F; Yang, CQ; Zhang, YD; Zhao, HD; Zhao, YL; Zhou, JS; Zhu, JR | 1 |
| Date, I; Haruma, J; Hui, Z; Liu, K; Liu, R; Mori, S; Nishibori, M; Nishimura, Y; Okuma, Y; Takahashi, HK; Teshigawara, K; Wake, H; Yamamoto, H; Yamamoto, Y | 1 |
2 other study(ies) available for glycyrrhizic acid and Brain Swelling
| Article | Year |
|---|---|
Berberine attenuates ischemia-reperfusion injury through inhibiting HMGB1 release and NF-κB nuclear translocation.
Topics: Animals; Berberine; Brain; Brain Edema; Down-Regulation; Glycyrrhizic Acid; HMGB1 Protein; Infarction, Middle Cerebral Artery; Interleukin-1beta; Interleukin-6; Male; Mice, Inbred C57BL; Neuroprotective Agents; NF-kappa B p50 Subunit; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |
Glycyrrhizin inhibits traumatic brain injury by reducing HMGB1-RAGE interaction.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Edema; Brain Injuries; Capillary Permeability; Cognition; Disease Models, Animal; Dose-Response Relationship, Drug; Glycyrrhizic Acid; HMGB1 Protein; Male; Mice, Knockout; Motor Activity; Neuroprotective Agents; Random Allocation; Rats, Wistar; Receptor for Advanced Glycation End Products; Receptors, Immunologic | 2014 |